Ketamine Treatment Plans for Chronic Conditions
Purpose
A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.
Conditions
- Chronic Pain
- Depressive Disorder
- Anxiety Disorders
- Chronic Disease
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Genders
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
Must have an identifiable chronic condition.
Exclusion Criteria
Healthy population
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Cross-Sectional
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Chronic Pain | The use of ketamine in chronic pain |
|
| Depressive Disorders | The use of ketamine in depressive disorders |
|
| Anxiety Disorders | The use of ketamine in anxiety disorders |
|
| Chronic Condtions | The use of ketamine in chronic conditions |
|
Recruiting Locations
More Details
- Status
- Recruiting
- Sponsor
- RIVER Foundation
Detailed Description
Ketamine can be administered in multiple ways (IV, IM, SubQ, and Sublingual, among others), and there have been few if any, studies that have compared the impact of Ketamine at home without any thearpy. The study will identify other treatment modalities used in concurrence with Ketamine. Psychotherapy, music therapy, and acutherapy are some of the most popular. How do these adjunct therapies affect the outcomes of Ketamine treatments? Secondarily, the study will focus on these significant issues to observe the impact of Ketamine treatments and suicidal ideation. Suicidal ideation is multifaceted and is one reason for prescribing off-label Ketamine. Chronic issues such as depression, pain, and anxiety have been identified as underlying causes and may be improvable with Ketamine.
